Sandbox Reserved 1502: Difference between revisions
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
====Structure and interaction with the antiviral==== | ====Structure and interaction with the antiviral==== | ||
The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with <scene name='80/802676/Site_of_interaction/ | The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with <scene name='80/802676/Site_of_interaction/4'>the site which bind to the LEDGF/p75 cofactor</scene>. This site is situated in the core domain. | ||
The molecule | The molecule then inhibits the interaction between the LEDGF/p75 cofactor and the integrase. | ||